DIFFERENCES IN SENSITIVITY TO FARNESOL TOXICITY BETWEEN NEOPLASTICALLY-DERIVED AND NON-NEOPLASTICALLY-DERIVED CELLS IN CULTURE

被引：54

作者：

ADANY, I

YAZLOVITSKAYA, EM

HAUG, JS

VOZIYAN, PA

MELNYKOVYCH, G

机构：

[1] UNIV KANSAS,MED CTR,DEPT MICROBIOL MOLEC GENET & IMMUNOL,KANSAS CITY,KS 66103

[2] DEPT VET AFFAIRS MED CTR,RES SERV,KANSAS CITY,MO 64128

来源：

CANCER LETTERS | 1994年 / 79卷 / 02期

关键词：

FARNESOL; TOXICOLOGY; CELL CULTURES;

D O I：

10.1016/0304-3835(94)90257-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Six neoplastically-derived cell lines and three cell lines derived from normal tissues were compared for their sensitivity to isoprenoid irons-trans farnesol. Assays of cell numbers and of protein concentrations per culture revealed greater sensitivity of neoplastic cells than of the normal cells. Similar differences were obtained from the comparison of incorporation of [methyl-H-3]choline into cellular lipids, with neoplastic cells showing greater inhibition than normal cells.

引用

页码：175 / 179

页数：5

共 15 条

[11] HEXADECYLPHOSPHOCHOLINE - PRECLINICAL AND THE 1ST CLINICAL-RESULTS OF A NEW ANTITUMOR DRUG
UNGER, C
EIBL, H
[J]. LIPIDS, 1991, 26 (12) : 1412 - 1417
[12] COMPARISON OF SELECTIVE CYTOTOXICITY OF ALKYL LYSOPHOSPHOLIPIDS
VOGLER, WR
OLSON, AC
OKAMOTO, S
SHOJI, M
RAYNOR, RL
KUO, JF
BERDEL, WE
EIBL, H
HAJDU, J
NOMURA, H
[J]. LIPIDS, 1991, 26 (12) : 1418 - 1423
[13] FARNESOL INHIBITS PHOSPHATIDYLCHOLINE BIOSYNTHESIS IN CULTURED-CELLS BY DECREASING CHOLINEPHOSPHOTRANSFERASE ACTIVITY
VOZIYAN, PA
GOLDNER, CM
MELNYKOVYCH, G
[J]. BIOCHEMICAL JOURNAL, 1993, 295 : 757 - 762
[14] RELATIONSHIP BETWEEN APOPTOSIS AND THE CELL-CYCLE IN LYMPHOCYTES - ROLES OF PROTEIN-KINASE-C, TYROSINE PHOSPHORYLATION, AND AP1
WALKER, PR
KWASTWELFELD, J
GOURDEAU, H
LEBLANC, J
NEUGEBAUER, W
SIKORSKA, M
[J]. EXPERIMENTAL CELL RESEARCH, 1993, 207 (01) : 142 - 151
[15] GROWTH-INHIBITION EFFECTS OF OLEIC-ACID, LINOLEIC-ACID, AND THEIR METHYL-ESTERS ON TRANSPLANTED TUMORS IN MICE
ZHU, YP
SU, ZW
LI, CH
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (17): : 1302 - 1306

← 1 2 →